Literature DB >> 16887810

HIV-1 TAR RNA subverts RNA interference in transfected cells through sequestration of TAR RNA-binding protein, TRBP.

Yamina Bennasser1, Man Lung Yeung, Kuan-Teh Jeang.   

Abstract

TAR RNA-binding protein, TRBP, was recently discovered to be an essential partner for Dicer and a crucial component of the RNA-induced silencing complex (RISC), a critical element of the RNA interference (RNAi) of the cell apparatus. Human TRBP was originally characterized and cloned 15 years ago based on its high affinity for binding the HIV-1 encoded leader RNA, TAR. RNAi is used, in part, by cells to defend against infection by viruses. Here, we report that transfected TAR RNA can attenuate the RNAi machinery in human cells. Our data suggest that TAR RNA sequesters TRBP rendering it unavailable for downstream Dicer-RISC complexes. TAR-induced inhibition of Dicer-RISC activity in transfected cells was partially relieved by exogenous expression of TRBP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887810     DOI: 10.1074/jbc.C600072200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs.

Authors:  Sylvanne M Daniels; Lucile Sinck; Natalie J Ward; Carlos E Melendez-Peña; Robert J Scarborough; Ibrahim Azar; Elodie Rance; Aïcha Daher; Ka-Ming Pang; John J Rossi; Anne Gatignol
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 2.  The roles of microRNAs in mammalian virus infection.

Authors:  Ralph Grassmann; Kuan-Teh Jeang
Journal:  Biochim Biophys Acta       Date:  2008-05-15

Review 3.  MicroRNA in the immune system, microRNA as an immune system.

Authors:  Li-Fan Lu; Adrian Liston
Journal:  Immunology       Date:  2009-07       Impact factor: 7.397

4.  The cellular TAR RNA binding protein, TRBP, promotes HIV-1 replication primarily by inhibiting the activation of double-stranded RNA-dependent kinase PKR.

Authors:  Viraj R Sanghvi; Laura F Steel
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

Review 5.  Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.

Authors:  Laurence Colin; Carine Van Lint
Journal:  Retrovirology       Date:  2009-12-04       Impact factor: 4.602

6.  Evidence for Alteration of Gene Regulatory Networks through MicroRNAs of the HIV-infected brain: novel analysis of retrospective cases.

Authors:  Erick T Tatro; Erick R Scott; Timothy B Nguyen; Shahid Salaria; Sugato Banerjee; David J Moore; Eliezer Masliah; Cristian L Achim; Ian P Everall
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

Review 7.  Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage.

Authors:  Valentin Le Douce; Georges Herbein; Olivier Rohr; Christian Schwartz
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

Review 8.  Human cellular restriction factors that target HIV-1 replication.

Authors:  Klaus Strebel; Jeremy Luban; Kuan-Teh Jeang
Journal:  BMC Med       Date:  2009-09-16       Impact factor: 8.775

Review 9.  Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome.

Authors:  Cheryl Bolinger; Kathleen Boris-Lawrie
Journal:  Retrovirology       Date:  2009-01-24       Impact factor: 4.602

10.  siRNA and shRNA screens advance key understanding of host factors required for HIV-1 replication.

Authors:  Kin-Hang Kok; Ting Lei; Dong-Yan Jin
Journal:  Retrovirology       Date:  2009-08-27       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.